Overexpression of S100A4 Predicts Migration, Invasion, and Poor Prognosis of Hypopharyngeal Squamous Cell Carcinoma

[1]  A. Shah,et al.  FKBP8 protects the heart from hemodynamic stress by preventing the accumulation of misfolded proteins and endoplasmic reticulum-associated apoptosis in mice , 2018, Journal of molecular and cellular cardiology.

[2]  Shiwu Zhang,et al.  S100A4 in cancer progression and metastasis: A systematic review , 2017, Oncotarget.

[3]  H. van Dam,et al.  Molecular insights into tumour metastasis: tracing the dominant events , 2017, The Journal of pathology.

[4]  W. Wang,et al.  Contribution of upregulated dipeptidyl peptidase 9 (DPP9) in promoting tumoregenicity, metastasis and the prediction of poor prognosis in non‐small cell lung cancer (NSCLC) , 2017, International journal of cancer.

[5]  P. Rudland,et al.  S100A4 Elevation Empowers Expression of Metastasis Effector Molecules in Human Breast Cancer. , 2017, Cancer research.

[6]  Daehoon Park,et al.  Prognostic significance of S100A4-expression and subcellular localization in early-stage breast cancer , 2017, Breast Cancer Research and Treatment.

[7]  Y. Atlasi,et al.  The role of S100a4 (Mts1) in Apc- and Smad4-driven tumour onset and progression. , 2016, European journal of cancer.

[8]  J. Nesland,et al.  Prognostic significance of S100A4 expression in stage II and III colorectal cancer: results from a population‐based series and a randomized phase III study on adjuvant chemotherapy , 2016, Cancer medicine.

[9]  Bhuvanesh Singh,et al.  Targeting cellular and molecular drivers of head and neck squamous cell carcinoma: current options and emerging perspectives , 2016, Cancer and Metastasis Reviews.

[10]  R. Ganju,et al.  Conditioning solid tumor microenvironment through inflammatory chemokines and S100 family proteins. , 2015, Cancer letters.

[11]  David J Weber,et al.  S100 proteins in cancer , 2015, Nature Reviews Cancer.

[12]  Juan Wang,et al.  Aberrant Expression of Beclin-1 and LC3 Correlates with Poor Prognosis of Human Hypopharyngeal Squamous Cell Carcinoma , 2013, PloS one.

[13]  V. Adhami,et al.  The S100A4 Oncoprotein Promotes Prostate Tumorigenesis in a Transgenic Mouse Model: Regulating NFκB through the RAGE Receptor. , 2013, Genes & cancer.

[14]  Kevin Fung,et al.  Frequent mutations in TP53 and CDKN2A found by next-generation sequencing of head and neck cancer cell lines. , 2012, Archives of otolaryngology--head & neck surgery.

[15]  P. Bradley,et al.  Current trends in initial management of hypopharyngeal cancer: The declining use of open surgery , 2012, Head & neck.

[16]  Raghu Kalluri,et al.  VEGF-A and Tenascin-C produced by S100A4+ stromal cells are important for metastatic colonization , 2011, Proceedings of the National Academy of Sciences.

[17]  M. Rugge,et al.  Nuclear expression of S100A4 calcium‐binding protein increases cholangiocarcinoma invasiveness and metastasization , 2011, Hepatology.

[18]  Mei Zhao,et al.  Assembly and Initial Characterization of a Panel of 85 Genomically Validated Cell Lines from Diverse Head and Neck Tumor Sites , 2011, Clinical Cancer Research.

[19]  Yau-Hua Yu,et al.  The epithelial-mesenchymal transition mediator S100A4 maintains cancer-initiating cells in head and neck cancers. , 2011, Cancer research.

[20]  J. Nesland,et al.  Nuclear S100A4 is a novel prognostic marker in colorectal cancer. , 2010, European journal of cancer.

[21]  Ming Yan,et al.  Correlation of NF-κB signal pathway with tumor metastasis of human head and neck squamous cell carcinoma , 2010, BMC Cancer.

[22]  Kjetil Boye,et al.  S100A4 and metastasis: a small actor playing many roles. , 2010, The American journal of pathology.

[23]  B. Nielsen,et al.  Lung metastasis fails in MMTV-PyMT oncomice lacking S100A4 due to a T-cell deficiency in primary tumors. , 2010, Cancer research.

[24]  C. Deng,et al.  Smad4 loss in mice causes spontaneous head and neck cancer with increased genomic instability and inflammation. , 2009, The Journal of clinical investigation.

[25]  C. Gourin,et al.  A contemporary review of indications for primary surgical care of patients with squamous cell carcinoma of the head and neck , 2009, The Laryngoscope.

[26]  S. Warnakulasuriya.  Global epidemiology of oral and oropharyngeal cancer. , 2009, Oral oncology.

[27]  J. Grandis,et al.  Head and neck squamous cell carcinoma cell lines: Established models and rationale for selection , 2007, Head & neck.

[28]  C. Heizmann,et al.  The metastasis-associated gene S100A4 is a novel target of beta-catenin/T-cell factor signaling in colon cancer. , 2006, Gastroenterology.

[29]  I. Konishi,et al.  Nuclear expression of S100A4 is associated with aggressive behavior of epithelial ovarian carcinoma: An important autocrine/paracrine factor in tumor progression , 2006, Cancer science.

[30]  M. Grigorian,et al.  Suppression of tumor development and metastasis formation in mice lacking the S100A4(mts1) gene. , 2005, Cancer research.

[31]  M. Grigorian,et al.  Extracellular S100A4(mts1) stimulates invasive growth of mouse endothelial cells and modulates MMP-13 matrix metalloproteinase activity , 2004, Oncogene.

[32]  M. Grigorian,et al.  Functional Significance of Metastasis-inducing S100A4(Mts1) in Tumor-Stroma Interplay* , 2004, Journal of Biological Chemistry.

[33]  D. Neal,et al.  Expression of S100A4 protein is associated with metastasis and reduced survival in human bladder cancer , 2002, The Journal of pathology.

[34]  D. Neal,et al.  Transfection of S100A4 produces metastatic variants of an orthotopic model of bladder cancer. , 2002, The American journal of pathology.

[35]  V. Berezin,et al.  The metastasis-associated Mts1(S100A4) protein could act as an angiogenic factor , 2001, Oncogene.

[36]  D. Sidransky,et al.  Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. , 2000, Journal of the National Cancer Institute.

[37]  J. Winstanley,et al.  Comparison of the metastasis‐inducing protein S100A4 (p9ka) with other prognostic markers in human breast cancer , 2000, International journal of cancer.

[38]  M. Mareel,et al.  E-cadherin and metastasin (mts-1/S100A4) expression levels are inversely regulated in two tumor cell families. , 1998, Cancer research.

[39]  Yohko Nakamura,et al.  Expression of antisense RNA to S100A4 gene encoding an S100-related calcium-binding protein suppresses metastatic potential of high-metastatic Lewis lung carcinoma cells , 1997, Oncogene.

[40]  E. Hovig,et al.  Reversal of the in vivo metastatic phenotype of human tumor cells by an anti-CAPL (mts1) ribozyme. , 1996, Cancer research.

[41]  P. Rudland,et al.  Expression of the calcium-binding protein S100A4 (p9Ka) in MMTV-neu transgenic mice induces metastasis of mammary tumours. , 1996, Oncogene.

[42]  M. Grigorian,et al.  Metastasis of mammary carcinomas in GRS/A hybrid mice transgenic for the mts1 gene. , 1996, Oncogene.

[43]  M. Grigorian,et al.  Effect of mts1 (S100A4) expression on the progression of human breast cancer cells , 1996, International journal of cancer.

[44]  D. Shedd,et al.  Metastatic patterns in squamous cell cancer of the head and neck. , 1987, American journal of surgery.

[45]  S. Rangan.  A new human cell line (FaDu) from a hypopharyngeal carcinoma , 1972, Cancer.

[46]  X. Xuan,et al.  S100A4 mediated cell invasion and metastasis of esophageal squamous cell carcinoma via the regulation of MMP-2 and E-cadherin activity , 2011, Molecular Biology Reports.

[47]  R. Gilbertson,et al.  ERBB2 up-regulates S100A4 and several other prometastatic genes in medulloblastoma. , 2003, Cancer research.